Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Mar. 31, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Dec. 31, 2025 |
|
| Accounting Policies [Line Items] | ||||||
| Cash used in operating activities | $ 54,537 | $ 55,552 | ||||
| Net proceeds from placement agreement | 65,400 | |||||
| Marketable securities and certain cash equivalents | $ 61,200 | $ 61,200 | $ 65,100 | |||
| Cost of Goods and Service Benchmark | Supplier Concentration Risk | Vendor One | Minimum | ||||||
| Accounting Policies [Line Items] | ||||||
| Concentration risk percentage | 10.00% | 10.00% | ||||
| As Previously Reported | ||||||
| Accounting Policies [Line Items] | ||||||
| Legal expenses | $ 1,800 | |||||
| Cost of revenue, research and development and sales and marketing expenses | $ 1,000 | |||||
| X | ||||||||||
- Definition Accounting Policies [Line Items] No definition available.
|
| X | ||||||||||
- Definition Cost of Revenue, Research and Development Expense and Selling and Marketing Expense No definition available.
|
| X | ||||||||||
- Definition Debt Securities, Available-for-Sale And Cash Equivalents No definition available.
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|